Skip to content
Head to head

Insulet vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: PODD · ABT

Updated 8 minutes ago

1-year performance, rebased to 100

PODD -59.4%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories has the highest Quant Rating (22); Abbott Laboratories has done best over the past year (-15%); Abbott Laboratories pays the highest dividend yield.
PODDABT
Snapshot
SectorMedical DevicesMedical Devices
Last price133.17103.00
Change today-2.96%-0.84%
1-year return-57.4%-15.4%
Market cap$9.24B$178.39B
52-week range126.40 – 342.1380.89 – 126.70
Valuation
P/E (TTM)21.7638.29
P/E percentile, own 5-yr range6th99th
P/B5.853.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)3.483.72
Net profit (TTM)$241.41M$6.44B
Revenue (TTM)$3.19B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+19.2%+14.5%
Gross margin71.9%56.9%
Operating margin18.4%13.8%
Net margin13.4%9.7%
Free cash flow (TTM)$232.60M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership99.6%81.2%
Insider activity (12mo)34 buy / 14 sell36 buy / 12 sell
Short interest (% of float)7.7%1.1%
Analyst consensus43% buy / 57% hold (14)93% buy / 7% hold (15)
Analyst price target$177 (+33%)$122 (+18%)
StockVane view
StockVane Quant RatingE (3)D (22)
Company
Employees5,400115,000
Founded20001900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.